Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas

BACKGROUND: Triple negative breast cancer (TNBC) in humans is defined by the absence of oestrogen receptor (ER), progesterone receptor (PR) and HER2 overexpression. Mammalian target of rapamycin (mTOR) is overexpressed in TNBC and it represents a potential target for the treatment of this aggressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Maniscalco, Lorella, Millán, Yolanda, Iussich, Selina, Denina, Mauro, Sánchez-Céspedes, Raquel, Gattino, Francesca, Biolatti, Bartolomeo, Sasaki, Nobuo, Nakagawa, Takayuki, Di Renzo, Maria Flavia, de las Mulas, Juana Martín, De Maria, Raffaella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637810/
https://www.ncbi.nlm.nih.gov/pubmed/23587222
http://dx.doi.org/10.1186/1746-6148-9-80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637810/
https://www.ncbi.nlm.nih.gov/pubmed/23587222
http://dx.doi.org/10.1186/1746-6148-9-80

Ejemplares similares